BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 121-140 of 216 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1212008Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerPiccart-Gebhart, Martine J.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sledge, George; Carmichael, James; Luck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
1222008The meta-analytic framework for the evaluation of surrogate endpoints in clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; BUYSE, MarcJournal ContributionA1
1232008Ensuring trial validity by data quality assurance and diversification of monitoring methodsBaigent, C.; Harrell, F.; BUYSE, Marc; Emberson, J.; Altman, D.Proceedings PaperC1
1242008Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission.BUYSE, Marc; Squifflet, Pierre; Rowe, Jacob M.; Whisnant, John K.; Bhagwat, Dileep; Allard, Stephane E.; Hellstrand, Kristoffer; Brune, Mats L.Journal ContributionM
1252008Reformulating the hazard ratio to enhance communication with clinical investigatorsBUYSE, MarcJournal ContributionA1
1262008Individual- and trial-level surrogacy in colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Michiels, Stefan; Carroll, KevinJournal ContributionA1
1272007Progression-free survival is a surrogate for survival in advanced colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, Kevin; Michiels, Stefan; Sargent, Daniel J.; Miller, Langdon L.; Elfring, Gary L.; Pignon, Jean-Pierre; Piedbois, PascalJournal ContributionA1
1282007Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!Collette, Laurence; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
1292007Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerde Gramont, Aimery; BUYSE, Marc; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Cervantes, Andres; Figer, Arie; Lledo, Gerard; Flesch, Michel; Mineur, Laurent; Carola, Elisabeth; Etienne, Pierre-Luc; Rivera, Fernando; Chirivella, Isabel; Perez-Staub, Nathalie; Louvet, Christophe; André, Thierry; Tabah-Fisch, Isabelle; Tournigand, ChristopheJournal ContributionA1
1302006Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trialBogaerts, J.; Cardoso, F.; BUYSE, Marc; Braga, S.; Loi, S.; Harrison, J. A.; Bines, J.; Mook, S.; Decker, N.; Ravdin, P.; Therasse, P.; Rutgers, E.; van't Veer, L. J.; Piccart, M.Journal ContributionA1
1312006Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validationBURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
1322006Analysis of oxaliplatin reintroduction in patients with advanced colorectal cancer (CRC) treated with FOLFOX4 or FOLFOX7 in the optimox studyBUYSE, Marc; Quinaux, E; CORTINAS ABRAHANTES, Jose; Tournigand, C; Cervantes, A; Figer, A; André, Thierry; Tabah-Fisch, I; De Gramont, AJournal ContributionM
1332006A unifying approach for surrogate marker validation based on Prentice's criteriaALONSO ABAD, Ariel; MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc; VANGENEUGDEN, TonyJournal ContributionA1
1342006Current issues in adjuvant treatment of stage II colon cancerAndré, Thierry; Sargent, D; Tabernero, J; O'Connell, M; BUYSE, Marc; Sobrero, A; Misset, J.L.; Boni, C; de Gramont, AJournal ContributionA1
1352006Alternative clinical end points in rectal cancer—are we getting closer?Glynne-Jones, R; Mawdsley, S; Pearce, T; BUYSE, MarcJournal ContributionA1
1362005The evaluation of surrogate endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, MarcBookB1
1372005Notation and motivating studiesMOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszBook SectionB2
1382005Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 tandomized trialsSargent, Daniel J.; Wieand, Harry S.; Haller, Daniel G.; Gray, Richard; Benedetti, Jacqueline; BUYSE, Marc; Labianca, Roberto; Seitz, Jean Francois; O'Callaghan, Christopher J.; Francini, Guido; Grothey, Axel; O'Connell, Michael; Catalano, Paul J.; Blanke, Charles D.; Kerr, David; Green, Erin; Wolmark, Norman; André, Thierry; Goldberg, Richard M.; De Gramont, AimeryJournal ContributionA1
1392005Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials.BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, K; Michiels, Stefan; Pignon, JP; Piedbois, PJournal ContributionM
1402005Setting the sceneMOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszBook SectionB2
show all